At a glance
Read the record in context
BPC-157's four recording routes sit beside a much narrower evidence base: a rat intravenous timing reference and preclinical intramuscular exposure data. That mismatch is the first fact to carry away from the card. The 5 mg catalog vial adds package information, not human route validation.[1]
What the research says
The cited pharmacokinetic study investigated BPC-157 in rats and beagle dogs after intravenous and intramuscular administration. Researchers measured absorption, tissue distribution, metabolism, and excretion, using both intact-peptide assays and radiolabeled material. This was an animal disposition study, rather than a human study of injury recovery.[2]
Intact BPC-157 had an elimination half-life below 30 minutes in the studied animals. Intramuscular bioavailability differed by species: approximately 14% to 19% in rats and 45% to 51% in dogs. The library's quarter-hour reference derives from the rat intravenous context and retains that species qualification.[2][1]
Radioactivity measurements followed peptide fragments through urine and bile, while metabolism produced smaller peptides and amino acids. Tracking a radioactive label can therefore capture material after the original peptide has broken down. These experiments do not provide a measured human subcutaneous half-life or establish a combined BPC-157 and TB-500 regimen.[2][1]
Cited amounts
The library records 5 mg as a supplier catalog package amount. This is the total listed in that presentation, not an amount selected for administration. No personal dosing range is inferred from it.[1][3]
Explore the BPC-157 dosing chartHalf-life and timing
A quarter-hour input produces a very short mathematical axis. The example drops to 25% after 30 minutes and 6.25% after 60 minutes. Its fifth halving occurs after 75 minutes, with 3.125% remaining. The precision comes from multiplying 15 minutes, not from measuring a human BPC-157 profile. The rat intravenous origin remains attached to every point. Neither a subcutaneous log nor an oral log turns this arithmetic into a measured route-specific human elimination curve.[1][5]
Explore the BPC-157 half-life modelReconstitution
The package lists 5 mg, equivalent to 5,000 micrograms by unit conversion. If a hypothetical final liquid volume were 2 mL, it would contain 2.5 mg/mL, or 2,500 micrograms/mL. A 0.1 mL portion in that example represents 250 micrograms. Those numbers illustrate the same quantity expressed at different scales. They are not a BPC-157 amount selected from human research, and the assumed liquid volume is not an instruction for preparing the catalog material.[3]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[4]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- What does a BPC-157 dosing chart establish?
- A chart can show conversions from an entered amount, but the library's rat reference does not establish a human dosing schedule. Its 5 mg vial is a supplier package fact. Any numeric conversion remains separate from the limited human evidence described in the guide.[1][2]
- Does a BPC-157 calculator convert milligrams to micrograms?
- One milligram equals 1,000 micrograms in the arithmetic used here. Thus the 5 mg package represents 5,000 micrograms in total. Converting units preserves the quantity and does not turn the catalog total into a human research amount.[1][5]
- Does the BPC-157 guide establish a BPC-157 and TB-500 blend schedule?
- No combined schedule is derived. The BPC-157 reference is preclinical and the TB-500 record has a different source context. Placing both names in a search phrase or calculator does not create evidence for the composition or timing of a blend.[1][5]
- Can a peptide tracker app record BPC-157?
- PinPoint's compound library includes BPC-157. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][4]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, BPC-157Snapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- Preclinical pharmacokinetics study PMC9794587Identity and research summary checked against this document on 5 October 2026. Abstract and relevant methods/results or product-monograph sections.Retrieved 2026-10-05 · library-reference
- Supplier catalog package referencePackage amount only; not a clinical amount or endorsement.Retrieved 2026-10-05 · supplier
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic